US 7728004
Crystalline form of a quinolinone-carboxamide compound
granted A61KA61K31/46A61P
Quick answer
US patent 7728004 (Crystalline form of a quinolinone-carboxamide compound) held by Theravance, Inc. expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/46, A61P, A61P1/00, A61P1/04